Source: Research Seminar 2013 - Optimising models for human lung diseases and drug development



Rating:

Share or cite this content

Citations should be made in the following way:
C. Guignabert (Creteil, France). Pulmonary Hypertension. Research Seminar 2013 - Optimising models for human lung diseases and drug development

Member's Comments

No comment yet.

Related content which might interest you: Pulmonary Hypertension in Childhood Source: Virtual Congress 2020 – From the bronchoscope to the clinic: paediatric bronchology at a glance Year: 2020 Clinical efficacy of Macitentan in patients with Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension Source: International Congress 2018 – Pulmonary hypertension: therapy Year: 2018 Nebivolol and pulmonary hypertension Source: International Congress 2014 – Pulmonary hypertension: pathobiology Year: 2014 Pulmonary Hypertension and IPF? Source: Virtual Congress 2021 – Pulmonary hypertension and interstitial pulmonary fibrosis Year: 2021 Pulmonary arterial hypertension – A single-centre experience Source: International Congress 2014 – Pulmonary hypertension: clinical management Year: 2014 Immune signatures in pulmonary arterial hypertension Source: International Congress 2014 – Pulmonary hypertension: novel targets and drugs Year: 2014 Association between Leflunomide and Pulmonary Hypertension Source: Virtual Congress 2021 – All about pulmonary arterial hypertension Year: 2021 Clinical Features of Pulmonary Hypertension Source: School Course 2012 - Pulmonary hypertension and pulmonary vascular disease Year: 2012 Effects on Right Ventricular size and function by Riociguat in Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension (The RIVER Study) Source: International Congress 2018 – Pulmonary hypertension: therapy Year: 2018 Pulmonary Hypertension in Hemodialysis Patients Source: International Congress 2018 – Clinical aspects of pulmonary hypertension Year: 2018 Pulmonary Hypertension in Pulmonary tuberculosis- A Prognostic Indicator Source: International Congress 2017 – Imaging and lung disease PH Year: 2017 Long-term screening for pulmonary hypertension after pulmonary embolism Source: International Congress 2014 – Chronic thromboembolic pulmonary hypertension Year: 2014 Endothelial-to-mesenchymal transition in pulmonary hypertension Source: International Congress 2014 – Pulmonary hypertension: novel targets and drugs Year: 2014 Exercise-induced pulmonary hypertension in patients with systemic sclerosis: Pilot-study Source: International Congress 2014 – Pulmonary hypertension: clinical management Year: 2014 Prognosis factors of recurrent pulmonary thromboembolism Source: International Congress 2014 – Acute pulmonary embolism Year: 2014